https://www.selleckchem.com/pr....oducts/Paclitaxel(Ta
A total of 53 (58.2 %) patients survived while 38(41.8 %) patients succumbed. Delay in presentation to hospital, intracranial extension and loss of vision at presentation adversely affected the outcome (p 0.05). Aggressive surgical management in the form of multiple debridements was superior to single debridement (p 0.05). Diabetic ketoacidosis did not significantly affect the outcome (p = 0.359). ROCM in patients with diabetes mellitus, is a rapidly progressive disease with a high fatality rate and grave outcome unl
Like
Comment
Share
